View Older Stories
-
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
-
Edwards Lifesciences (EW) Added as Top Pick at Citi, PODD Removed
-
Citi Removes Two names from 90-Day Catalyst Watch Lists
-
Citi Opens 90-Day Upside Catalyst Watch on Edwards Lifesciences (EW)
-
Edwards Lifesciences (EW) PT Lowered to $83 at Citi
-
MedTech stocks: Q2 earnings season preview
-
Becton Dickinson (BDX) to Acquire Edwards Lifesciences' (EW) Critical Care Product Group for $4.2B Cash
-
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
-
Citi Upgrades Edwards Lifesciences (EW) to Buy
-
Citi Downgrades Edwards Lifesciences (EW) to Neutral, 'Near term still transitional'
-
Edwards Lifesciences (EW) tumbles as guidance misses expectations
-
Citi Opens Downside 90-Day Catalyst Watch on Edwards Lifesciences (EW)
-
Citi on Edwards Lifesciences (EW): Opening Upside 90-Day Catalyst Watch
-
Citi Remains Bullish on Edwards Lifesciences (EW), Removes from NAM Focus List
-
UPDATE: Citi Upgrades Edwards Lifesciences (EW) to Buy
-
Pre-Open 10/24: (TSLA) (AYR) (PYPL) Higher (ACOR) (TWTR) (TXMD) Lower (more...)
-
Edwards Lifesciences (EW) PT Raised to $159 at Citi
-
Edwards Lifesciences (EW) PT Raised to $154 at Citi
-
Edwards Lifesciences (EW) PT Raised to $130 at Citi
-
Edwards Lifesciences (EW) PT Raised to $119 at Citi
-
Edwards Lifesciences (EW) PT Lowered to $118 at Citi
-
Edwards Lifesciences (EW) PT Raised to $121 at Citi
-
Edwards Lifesciences (EW) PT Raised to $118 at Citi
-
Edwards Lifesciences (EW) PT Raised to $115 at Citi
-
Edwards Lifesciences (EW) PT Raised to $106 at Citi
-
Edwards Lifesciences (EW) PT Raised to $99 at Citi
-
A Deep Dive into Modeling the TAVR Market: Sell Edward Lifesciences (EW) / Buy Boston Scientific (BSX) - Citi
-
Citi Starts Edwards Lifesciences (EW) at Sell
-
Pre-Open Stock Movers 4/14: (AHL) (WBMD) (TWTR) Higher; (MDT) (ACOR) (TSL) Lower (more...)
-
Notable Analyst Rating Changes 10/16: (INTC) (S) (JNPR) Upgraded; (VVUS) (ELLI) (ACI) Downgraded
-
Citi Upgrades Edwards Lifesciences (EW) to Buy
-
Streetinsider.com Pre-Open Movers 07/12: (WBMD) (SPRD) (INFY) Higher; (CERE) (UPS) (SODA) Lower (more...)
-
Citi Downgrades Edwards Lifesciences (EW) to Neutral
-
Pre-Open Movers 10/09: (SPB) (RSH) (QCOR) Higher; (EW) (OC) (NFLX) Lower (more...)
-
After-Hours Movers 10/08: (EW) (ANGO) (COV) Lower (more...)
-
Notable Analyst Rating Changes 07/13: (KMI) (RRC) (DHI) Upgraded; (SKS) (DF) (EW) Downgraded
-
Pre-Open Movers 2/3: (ZOLG) (GILD) (URBN) Higher; (THQI) (EW) (APKT) Lower (more...)
-
Notable Analyst Rating Changes 01/18: (MGM) (RSH) (CREE) Upgraded; (TSN) (GOOG) (JNS) Downgraded
-
Notable Analyst Rating Changes 12/12: (BA) (BYI) (EW) Upgraded; (CRM) (AVGO) (KOG) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Daily State of the Markets 09/28: Second Thoughts?
-
Notable Analyst Rating Changes 09/23: EW, MYL, NVDA, ENDP Upgraded; DYN, MO, OXPS, CVVT Downgraded
-
Citi Maintains a 'Hold' on Cooper Companies (COO); Positive Q3 EPS, but is GM Sustainable?
-
Citi Maintains a 'Hold' on Integra Lifesciences Holdings (IART); Highlights from Meetings with Management at AANS
-
Citi Maintains a 'Buy' on Edwards Lifesciences (EW); Raises Price Target
-
Citi Upgrades Edwards Lifesciences (EW) to Buy
-
Citi Upgrades Edwards Lifesciences (EW) to Hold

